[Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis]. 2001

G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
Departamento de Pediatría y Laboratorio de Desarrollo y Biología Molecular, Facultad de Medicina, Pontificia Universidad Católica de Chile. grepetto@med.puc.cl

BACKGROUND Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CFTR gene, that codes for a chloride channel located in the apical surface of epithelial cells. The main role of this protein is the regulation of chloride transport, and secondarily, of sodium and water to the extracellular space. More than 900 gene mutations have been described, and their relative frequency in different populations depends on their ethnic origin. OBJECTIVE To report the findings of Chilean patients with cystic fibrosis, in whom the presence of 20 common mutations was analyzed. METHODS Fifty seven patients with established diagnosis or suspicion of CF were studied. The simultaneous identification of 20 mutations and the normal delta F508 allele was done using polymerase chain reactions with a commercial assay. RESULTS Eight mutations were found. Fifty patients fulfilled diagnostic criteria proposed by the Consensus Panel of the CF Foundation and 66% of alleles were identified in this group. delta F508 mutation was found in 45%. We did not identify mutations in any of the remaining 7 patients. CONCLUSIONS Our results suggest that the majority of undetected mutations are associated with atypical phenotypes or that some patients in this series could have other diseases. We recommend to include mutation analysis in the evaluation of Chilean patients with CF. It is useful to establish prognosis and genetic counselling.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002677 Chile A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru.
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females

Related Publications

G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
January 1992, The EMBO journal,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
October 1992, British medical bulletin,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
September 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
August 2002, Journal of hepatology,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
June 2007, Fertility and sterility,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
March 1993, American journal of human genetics,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
September 2000, Anais da Academia Brasileira de Ciencias,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
July 2002, Journal of dental research,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
January 2001, Respiratory research,
G Repetto, and H Poggi, and P Harris, and H Navarro, and I Sánchez, and E Guiraldes, and M A Pérez, and M L Boza, and B Hunter, and M E Wevar, and M Mediavilla, and A Foradori
February 2021, Cureus,
Copied contents to your clipboard!